Multiple Criteria Decision Analysis for Off-Patent Pharmaceuticals in Health Care: Bibliometric Analysis and Scoping Review

https://doi.org/10.22146/jmpf.100349

Ratih Puspita Febrinasari(1*), Erna Kristin(2), Aiman Hilmi Asaduddin(3), Meutia Filzan Kamilah(4), Dinari Febriyanti(5)

(1) Department of Pharmacology, Faculty of Medicine, Sebelas Maret University, Surakarta, Central Java, Indonesia
(2) Department of Pharmacology and Therapy, Faculty of Medicine, Public Health and Nursing, Gadjah Mada University, Yogyakarta
(3) Department of Pharmacology, Faculty of Medicine, Sebelas Maret University, Surakarta, Central Java
(4) Department of Pharmacology, Faculty of Medicine, Sebelas Maret University, Surakarta, Central Java
(5) Department of Pharmacology, Faculty of Medicine, Sebelas Maret University, Surakarta, Central Java
(*) Corresponding Author

Abstract


Background: Multi-Criteria Decision Analysis (MCDA) is a structured approach used for evaluating complex decisions that involve multiple criteria. In the context of healthcare, its use has grown significantly for benefit–risk assessments, formulary decisions, and reimbursement processes. In developing countries, MCDA has been proposed to support evidence-based evaluation of off-patent pharmaceuticals (OPPs), helping improve public health outcomes and access to quality medicines. However, existing reviews remain limited in scope, emphasizing the need for an updated bibliometric overview of MCDA applications in OPPs.

Objectives: This study aims to provide a comprehensive bibliometric analysis of MCDA research in healthcare, with a specific focus on OPPs.

Methods: Searches were conducted in Scopus, PubMed, and Epistemonikos from January 1985 to October 2023. Eligible studies included full-text English articles utilizing MCDA in OPP procurement. Data were extracted on decision contexts, criteria, methodologies, and stakeholder involvement. Bibliometric analysis was conducted using Scopus Analyzer, VOSviewer, and Microsoft Excel.

Results: A total of 2,210 MCDA-related healthcare articles were identified from 1981 to 2023, with a marked increase after 2013. Dominant themes included decision-making, multicriteria analysis, and healthcare. The identification results showed that A.A. Zaidan was the most prolific author. Citation analysis reported 41,882 citations between 2011 and 2023. The scoping review identified seven studies focusing on MCDA for OPPs, highlighting quality as the most prioritized criterion in procurement frameworks.

Conclusion: MCDA frameworks offer a comprehensive approach to improve healthcare decision-making and policy development, particularly in evaluating and procuring OPPs, while supporting adaptable implementation across diverse health systems.


Keywords


Bibliometric analysis; Healthcare; Multicriteria decision analysis; Off-patent pharmaceuticals; Scoping review

Full Text:

PDF


References

  1. Inotai A, Brixner D, Maniadakis N, Dwiprahasto I, Kristin E, Prabowo A, et al. Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals: an application on improving tender decision making in Indonesia. BMC Health Serv Res. 2018;18:1003. doi:10.1186/s12913-018-3805-3
  2. Baran-Kooiker A, Czech M, Kooiker C. Multi-criteria decision analysis (MCDA) models in health technology assessment of orphan drugs: a systematic literature review—next steps in methodology development? Front Public Health. 2018;6:287. doi:10.3389/fpubh.2018.00287
  3. Broekhuizen H, Groothuis-Oudshoorn CGM, van Til JA, Hummel JM, IJzerman MJ. A review and classification of approaches for dealing with uncertainty in multi-criteria decision analysis for healthcare decisions. Pharmacoeconomics. 2015;33(5):445–55. doi:10.1007/s40273-014-0251-x
  4. Thokala P, Devlin N, Marsh K, Baltussen R, Boysen M, Kalo Z, et al. Multiple criteria decision analysis for health care decision making: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force. Value Health. 2016;19(1):1–13. doi:10.1016/j.jval.2015.12.003
  5. Cinelli M, Kadziński M, Gonzalez M, Słowiński R. How to support the application of multiple criteria decision analysis? Let us start with a comprehensive taxonomy. Omega. 2020;96:102261. doi:10.1016/j.omega.2020.102261
  6. Mühlbacher AC, Kaczynski A. Making good decisions in healthcare with multi-criteria decision analysis: the use, current research and future development of MCDA. Appl Health Econ Health Policy. 2016;14(1):29–40. doi:10.1007/s40258-015-0203-4
  7. Kolasa K, Zah V, Kowalczyk M. How can multi-criteria decision analysis support value assessment of pharmaceuticals? Findings from a systematic literature review. Expert Rev Pharmacoecon Outcomes Res. 2018;18(4):379–91. doi:10.1080/14737167.2018.1467759
  8. Brixner D, Maniadakis N, Kaló Z, Hu S, Shen J, Wijaya K. Applying multi-criteria decision analysis (MCDA) simple scoring as an evidence-based HTA methodology for evaluating off-patent pharmaceuticals in emerging markets. Value Health Reg Issues. 2017;13:1–6. doi:10.1016/j.vhri.2017.02.001
  9. Abdullah AH, Holtorf AP, Al-Hussaini M, Lemay J, Alowayesh MK. Stakeholder-driven development of a multi-criteria decision analysis tool for purchasing off-patent pharmaceuticals in Kuwait. J Pharm Policy Pract. 2019;12:17. doi:10.1186/s40545-019-0171-4
  10. Gongora-Salazar P, Rocks S, Fahr P, Rivero-Arias O, Tsiachristas A. The use of multicriteria decision analysis to support decision making in healthcare: an updated systematic literature review. Value Health. 2023;26(5):780–90. doi:10.1016/j.jval.2022.11.007
  11. Dai Z, Xu S, Wu X, et al. Knowledge mapping of multicriteria decision analysis in healthcare: a bibliometric analysis. Front Public Health. 2022;10:895552. doi:10.3389/fpubh.2022.895552
  12. Adunlin G, Diaby V, Xiao H. Application of multicriteria decision analysis in health care: a systematic review and bibliometric analysis. Health Expect. 2015;18(6):1894–905. doi:10.1111/hex.12287
  13. Cilmiaty R, Ilyas MF. A bibliometrics and scientometrics study of mineral trioxide aggregate material for irreversible pulpitis. J Med Chem Sci. 2024;7(5):729–43. doi:10.26655/JMCHEMSCI.2024.5.9
  14. Hu S, Zhang Y, He J, et al. A case study of pharmaceutical pricing in China: setting the price for off-patent originators. Appl Health Econ Health Policy. 2015;13(1):13–20. doi:10.1007/s40258-014-0150-5
  15. Brixner D, Kaló Z, Maniadakis N, Kim K, Wijaya K. An evidence framework for off-patent pharmaceutical review (EFOR) for health technology assessment in emerging markets. Value Health Reg Issues. 2018;16:9–13. doi:10.1016/j.vhri.2018.01.003
  16. Farghaly MN, Al Dallal SAM, Fasseeh AN, et al. Recommendation for a pilot MCDA tool to support the value-based purchasing of generic medicines in the UAE. Front Pharmacol. 2021;12:680737. doi:10.3389/fphar.2021.680737
  17. Frazão TDC, Camilo DGG, Cabral ELS, Souza RP. Multicriteria decision analysis (MCDA) in health care: a systematic review of the main characteristics and methodological steps. BMC Med Inform Decis Mak. 2018;18(1):90. doi:10.1186/s12911-018-0663-1
  18. Holtorf AP, Kristin E, Assamawakin A, Upakdee N, Indrianti R, Apinchonbancha N. Case studies for implementing MCDA for tender and purchasing decisions in hospitals in Indonesia and Thailand. J Pharm Policy Pract. 2021;14(1):1–14. doi:10.1186/s40545-021-00333-8
  19. Oliveira MD, Mataloto I, Kanavos P. Multi-criteria decision analysis for health technology assessment: addressing methodological challenges to improve the state of the art. Eur J Health Econ. 2019;20(6):891–918. doi:10.1007/s10198-019-01052-3
  20. Pirri S, Lorenzoni V, Turchetti G. Scoping review and bibliometric analysis of Big Data applications for medication adherence. BMC Health Serv Res. 2020;20:688. doi:10.1186/s12913-020-05544-4
  21. Elezbawy B, Fasseeh AN, Sedrak A, et al. A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt. J Pharm Policy Pract. 2022;15(1):1–10. doi:10.1186/s40545-022-00414-2



DOI: https://doi.org/10.22146/jmpf.100349

Article Metrics

Abstract views : 0 | views : 2

Refbacks

  • There are currently no refbacks.


Copyright (c) 2026 JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

©Jurnal Manajemen dan Pelayanan Farmasi
Faculty of Pharmacy
Universitas Gadjah Mada
Creative Commons License
View My Stats